
Job-ID: 61697
Location: Wien, AUT
Job Level: Entry Level
Category: Technology Transfer
Employment Type: Temporary employment
Become part of a vital chain and contribute to our common goal of making people's lives better. Octapharma is one of the largest human protein manufacturers in the world, developing and producing medicines sourced from human plasma and human cell lines. We are a privately-owned company, where the warmth of family meets the scale of a global organisation.
With over 1600 employees, the Octapharma site in Vienna is the largest production site, and successful research and development location.
We are looking for a Project Manager (m/f/d) to join the International Production Integration (IPI) team within Group Project Management. You will drive technology transfer projects from initiation to handover and collaborate with interdisciplinary teams to implement new production processes and products across global sites.
The position is offered on a fixed-term basis as a parental leave cover until March 31, 2028.
Join us in shaping our vision to provide new health solutions advancing human life.
Enjoy these attractive benefits! You can find all offers here: Benefits
The minimum gross salary according to the collective agreement (chemical industry) is EUR 4,270.14 based on 38 hours per week (full-time). As we strive to offer a salary that reflects your individual profile and qualifications, there is a willingness to pay above the minimum salary.
We live diversity and stand for equal opportunities as an employer! We therefore look forward to receiving your application - regardless of age, gender, origin, sexual orientation, and religion.
Do you have any questions? Then get in touch with your contact person.
Stephanie Pistauer, BA MSc
Octapharma Pharmazeutika Produktionsges.m.b.H.
Oberlaaer Straße 235, 1100 Wien
T: +43 (1) 610 32 - 1308
Visit our website Octapharma Career and follow us daily on LinkedIn.
Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. We employ more than 11,000 people worldwide to support the treatment of patients in 120 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care. With seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany, and Sweden, Octapharma also operates over 195 plasma donation centres across Europe and the US. With four decades of experience, we are committed to advancing patient care worldwide.